Abnova (Taiwan) (TPE:4133) Cyclically Adjusted Book per Share: NT$23.88 (As of Dec. 2025)


TPE:4133 Abnova (Taiwan) Corp TPE:4133
75 GF Score
Price NT$21.20
GF Value NT$28.26
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Abnova (Taiwan) Cyclically Adjusted Book per Share?

Abnova (Taiwan) TPE:4133 +1.68% 75 Cyclically Adjusted Book per Share is NT$23.88 as of Dec. 2025. GuruFocus rates TPE:4133 with a GF Score™ of 75/100 and a GF Value™ of NT$28.26 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Abnova (Taiwan)'s adjusted book value per share for the three months ended in Dec. 2025 was NT$20.750. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$23.88 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Abnova (Taiwan)'s average Cyclically Adjusted Book Growth Rate was 0.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Abnova (Taiwan) was 3.40% per year. The lowest was 0.80% per year. And the median was 2.60% per year.

As of today (2026-07-07), Abnova (Taiwan)'s current stock price is NT$21.20. Abnova (Taiwan)'s Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$23.88. Abnova (Taiwan)'s Cyclically Adjusted PB Ratio of today is 0.89.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abnova (Taiwan) was 7.10. The lowest was 0.85. And the median was 1.47.


Abnova (Taiwan)  (TPE:4133) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abnova (Taiwan)'s Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=21.20/23.88
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abnova (Taiwan) was 7.10. The lowest was 0.85. And the median was 1.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Abnova (Taiwan) Cyclically Adjusted Book per Share Related Terms


Abnova (Taiwan) Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Abnova (Taiwan)'s Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abnova (Taiwan) Cyclically Adjusted Book per Share Chart

Abnova (Taiwan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.37 23.31 23.61 23.83 23.88

Abnova (Taiwan) Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.83 24.00 24.07 24.10 23.88

TPE:4133 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Abnova (Taiwan)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abnova (Taiwan) Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abnova (Taiwan)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abnova (Taiwan)'s Cyclically Adjusted PB Ratio falls into.


TPE:4133
75GF Score
Abnova (Taiwan) Corp TPE:4133
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abnova (Taiwan) Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abnova (Taiwan)'s adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=20.75/324.0540*324.0540
=20.750

Current CPI (Dec. 2025) = 324.0540.

Abnova (Taiwan) Quarterly Data

Book Value per Share CPI Adj_Book
201603 19.503 238.132 26.540
201606 19.071 241.018 25.641
201609 19.185 241.428 25.751
201612 19.424 241.432 26.071
201703 19.571 243.801 26.013
201706 19.625 244.955 25.962
201709 20.081 246.819 26.365
201712 20.225 246.524 26.586
201803 20.144 249.554 26.158
201806 19.546 251.989 25.136
201809 19.657 252.439 25.234
201812 20.267 251.233 26.141
201903 20.299 254.202 25.877
201906 19.844 256.143 25.105
201909 19.703 256.759 24.867
201912 19.692 256.974 24.832
202003 19.703 258.115 24.736
202006 19.743 257.797 24.817
202009 19.921 260.280 24.802
202012 20.000 260.474 24.882
202103 19.495 264.877 23.850
202106 19.576 271.696 23.348
202109 19.777 274.310 23.363
202112 20.011 278.802 23.259
202203 19.878 287.504 22.405
202206 20.033 296.311 21.909
202209 20.502 296.808 22.384
202212 21.336 296.797 23.295
202303 20.698 301.836 22.222
202306 20.929 305.109 22.229
202309 21.146 307.789 22.263
202312 21.243 306.746 22.442
202403 21.022 312.332 21.811
202406 21.340 314.175 22.011
202409 21.390 315.301 21.984
202412 21.624 315.605 22.203
202503 20.951 319.799 21.230
202506 20.329 322.561 20.423
202509 20.523 324.800 20.476
202512 20.750 324.054 20.750

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$23.88 mean?
Abnova (Taiwan) (TPE:4133) has a Cyclically Adjusted Book per Share of NT$23.88 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abnova (Taiwan) and its competitors.
Is Abnova (Taiwan)'s Cyclically Adjusted Book per Share too high?
Abnova (Taiwan)'s current Cyclically Adjusted Book per Share is NT$23.88. Overall, Abnova (Taiwan) has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abnova (Taiwan)'s Cyclically Adjusted Book per Share compare to VRTX and REGN?
Abnova (Taiwan)'s Cyclically Adjusted Book per Share of NT$23.88 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abnova (Taiwan) and its competitors. Abnova (Taiwan)'s current Cyclically Adjusted Book per Share is NT$23.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abnova (Taiwan) stock overvalued right now?
Based on GuruFocus' analysis, Abnova (Taiwan) (TPE:4133) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.26, compared to a current price of NT$21.20 — trading 25% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$23.88. Abnova (Taiwan)'s overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Abnova (Taiwan) (TPE:4133), the current Cyclically Adjusted Book per Share is NT$23.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abnova (Taiwan) (TPE:4133) Overvalued in 2026?

Based on GuruFocus' analysis, Abnova (Taiwan) stock appears to be undervalued. The current stock price of NT$21.20 is trading 25% below its estimated GF Value™ of NT$28.26. GuruFocus considers Abnova (Taiwan) to be Modestly Undervalued.

Key valuation signals for TPE:4133:

  • Cyclically Adjusted Book per Share: NT$23.88
  • GF Value™: NT$28.26 vs. price of NT$21.20 (25% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the TPE:4133 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abnova (Taiwan) Business Description

Address No.108, Jhouzih Street, 9th Floor, Neihu District, Taipei City, TWN
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries. It generates maximum revenue from America. Its products include: SARS-CoV/CoV-2, DNA, RNA new, Proteins/peptides, MaxPab, DNAxPab, Polyclonal Ab, Monoclonal Ab and Others. The company's services are: Gene synthesis & cytogenetics, Peptide services, Protein expression, Humanized antibody, Assay development, Conjugation, FFPE tumor tissue DNA, In situ hybridization (ISH) and Others.
75GF Score

Get the complete analysis for TPE:4133

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$21.20
Price
NT$28.26
GF Value